学术探索
学术期刊
新闻热点
数据分析
智能评审

The past, present and future of antimycotic combination therapy

被引：99
作者：
Polak, A
机构：
[1] CH4147 Aesch
来源：
MYCOSES | 1999年 / 42卷 / 5-6期
关键词：
antimycotic chemotherapy; combination therapy;
D O I：
10.1046/j.1439-0507.1999.00475.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：355 / 370
页数：16
相关论文
共 163 条
[1]   A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients [J].
AbeleHorn, M ;
Kopp, A ;
Sternberg, U ;
Ohly, A ;
Dauber, A ;
Russwurm, W ;
Buchinger, W ;
Nagengast, O ;
Emmerling, P .
INFECTION, 1996, 24 (06) :426-432
[2]   COMBINED THERAPY WITH FLUCONAZOLE AND FLUCYTOSINE IN MURINE CRYPTOCOCCAL MENINGITIS [J].
ALLENDOERFER, R ;
MARQUIS, AJ ;
RINALDI, MG ;
GRAYBILL, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :726-729
[3]  
ANAISSIE E, 1989, ICAAC 1989
[4]   COMPARATIVE EFFICACIES OF AMPHOTERICIN-B, TRIAZOLES, AND COMBINATION OF BOTH AS EXPERIMENTAL-THERAPY FOR MURINE TRICHOSPORONOSIS [J].
ANAISSIE, EJ ;
HACHEM, R ;
KARYOTAKIS, NC ;
GOKASLAN, A ;
DIGNANI, MC ;
STEPHENS, LC ;
TINU, CK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) :2541-2544
[5]  
[Anonymous], PROG DRUG RES
[6]   TREATMENT OF OPPORTUNISTIC FUNGAL-INFECTIONS [J].
ARMSTRONG, D .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (01) :1-9
[7]   COMPARISON OF FLUCONAZOLE, AMPHOTERICIN-B AND FLUCYTOSINE IN TREATMENT OF A MURINE MODEL OF DISSEMINATED INFECTION WITH CANDIDA-GLABRATA IN IMMUNOCOMPROMISED MICE [J].
ATKINSON, BA ;
BOUTHET, C ;
BOCANEGRA, R ;
CORREA, A ;
LUTHER, MF ;
GRAYBILL, JR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (05) :631-640
[8]   In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans [J].
Barchiesi, F ;
Di Francesco, LF ;
Compagnucci, P ;
Arzeni, D ;
Giacometti, A ;
Scalise, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :59-65
[9]   In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles [J].
Barchiesi, F ;
DiFrancesco, LF ;
Scalise, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1812-1814
[10]  
BARRETTBEE K, 1985, J GEN MICROBIOL, V131, P1217
12345678910